Log in to save to my catalogue

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fdc017c5a9c4d9aaef1fa5cec6b80ce

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

About this item

Full title

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

Publisher

London: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2022-07, Vol.41 (1), p.1-219, Article 219

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background The Hippo pathway functions as a tumor suppressor pathway in human cancers, while dysfunction of the Hippo pathway is frequently observed in malignancies. Although YAP/TAZ activity is tightly controlled by the phosphorylation cascade of the MST-LATS-YAP/TAZ axis, it is still unclear why the YAP/TAZ proteins are activated in human cancers...

Alternative Titles

Full title

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2fdc017c5a9c4d9aaef1fa5cec6b80ce

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fdc017c5a9c4d9aaef1fa5cec6b80ce

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-022-02410-5

How to access this item